Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicine

This page shows the latest Foundation Medicine news and features for those working in and with pharma, biotech and healthcare.

Roche agrees $2.4bn takeover of genomics player Foundation

Roche agrees $2.4bn takeover of genomics player Foundation

Roche agrees $2.4bn takeover of genomics player Foundation. Offers a 29% premium on the Foundation’s recent share price. ... Three years after taking a $1bn stake in Foundation Medicine, Roche has decided it wants to take complete control of the

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Biogen Idec appoints senior neuroscientists Biogen Idec appoints senior neuroscientists

    Dr Henderson was most recently Gurewitsch and Vidda Foundation professor of Rehabilitation and Regenerative Medicine at Columbia University in New York City. ... He was also professor of Molecular Medicine at the Lerner College of Medicine at Case

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    However, in precision medicine, we ask what treatment is best for the patient? ... Foundation Medicine has risen to this need with the launch and approval of their new  FoundationOne CDx, the first and only comprehensive genomic profiling test for all

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics